Two cases of spontaneous regression of multicentric hepatocellular carcinoma after intraperitoneal rupture: possible role of immune mechanisms

被引:17
作者
Blondon, H
Fritsch, L
Cherqui, D
机构
[1] Ctr Hosp Agglomerat Montargoise, Serv Gastroenterol, Dept Hepatogastroenterol, F-45207 Montargis, France
[2] Ctr Hosp, Dept Med Imaging, Montargis, France
[3] Hop Henri Mondor, Dept Gen & Digest Surg, F-94010 Creteil, France
关键词
hepatocellular carcinoma; spontaneous regression; liver tumour; immunology;
D O I
10.1097/00042737-200412000-00020
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
We report two cases of spontaneous regression of hepatocellular carcinoma. Firstly, a 64-year-old man with alcohol related cirrhosis developed multiple liver tumours with elevation of the alpha-fetoprotein level at 915 ng/ml. A spontaneous regression of all the tumoural masses but one and normalization of the alpha-fetoprotein level was observed after intraperitoneal spread of the malignancy. Resection of the remaining tumour 9 months later confirmed a hepatocellular carcinoma. Secondly, a 70-year-old woman with alcohol related cirrhosis developed multiple liver tumours with elevation of the alpha-fetoprotein level to 4000 ng/ml; a regression of all the tumoural masses but one and a decrease of the alpha-fetoprotein level to 400 ng/ml was observed after intraperitoneal spread of the malignancy and treatment with tamoxifen. We discuss a possible immune mechanism of tumoural regression with a review of similar cases described in the literature. (C) 2004 Lippincott Williams Wilkins.
引用
收藏
页码:1355 / 1359
页数:5
相关论文
共 40 条
[11]  
GOTTFRIED EB, 1982, GASTROENTEROLOGY, V82, P770
[12]  
GROSSMANN M, 1995, AM J GASTROENTEROL, V90, P1500
[13]  
Herrera A, 1996, AM J GASTROENTEROL, V91, P1288
[14]  
IMAOKA S, 1994, HEPATO-GASTROENTEROL, V41, P359
[15]  
Izuishi K, 2000, HEPATO-GASTROENTEROL, V47, P1122
[16]  
Jang Tae Jung, 2000, Korean Journal of Internal Medicine, V15, P147
[17]   Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trial [J].
Jocham, D ;
Richter, A ;
Hoffmann, L ;
Iwig, K ;
Fahlenkamp, D ;
Zakrzewski, G ;
Schmitt, E ;
Dannenberg, T ;
Lehmacher, W ;
von Wietersheim, J ;
Doehn, C .
LANCET, 2004, 363 (9409) :594-599
[18]  
Kaczynski J, 1998, HISTOPATHOLOGY, V32, P147
[19]  
LAM KC, 1982, CANCER, V50, P332, DOI 10.1002/1097-0142(19820715)50:2<332::AID-CNCR2820500228>3.0.CO
[20]  
2-O